2024
DOI: 10.1016/j.apsb.2023.09.017
|View full text |Cite
|
Sign up to set email alerts
|

The effect of lengths of branched-chain fatty alcohols on the efficacy and safety of docetaxel-prodrug nanoassemblies

Shuo Wang,
Tian Liu,
Yuetong Huang
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 35 publications
0
1
0
Order By: Relevance
“…Redox-responsive homodimer prodrugs (HPs) consist of two identical drug molecules bridged by a redox-responsive chemical linkage, which can spontaneously aggregate into nanoassemblies in aqueous medium without the need for adjunct carriers. Compared with carrier-dependent drug delivery systems such as liposomes and micelles, redox-responsive homodimer prodrug nanoassemblies (RHPNs) integrate the advantages of prodrugs and nanotechnology with ultrahigh drug loading efficiency (over 60%) and avoid carrier-related toxicity. In addition, the redox-responsive chemical linkage can be triggered by redox substances in the tumor-specific microenvironment, enabling selective drug release. ,, Recently, RHPNs have caught significant attention for their great potential to enhance the effectiveness and safety of chemotherapeutic agents. , Despite these advantages, RHPNs are currently only in the preclinical research stage, with their antitumor efficacy limited by the challenges of simultaneously enhancing assembly ability and drug release rate. , Therefore, constructing RHPNs with a suitable chemical linkage to simultaneously enhance the assembly ability and drug release rate is critical for ensuring stability in systemic circulation and antitumor response in tumors.…”
Section: Introductionmentioning
confidence: 99%
“…Redox-responsive homodimer prodrugs (HPs) consist of two identical drug molecules bridged by a redox-responsive chemical linkage, which can spontaneously aggregate into nanoassemblies in aqueous medium without the need for adjunct carriers. Compared with carrier-dependent drug delivery systems such as liposomes and micelles, redox-responsive homodimer prodrug nanoassemblies (RHPNs) integrate the advantages of prodrugs and nanotechnology with ultrahigh drug loading efficiency (over 60%) and avoid carrier-related toxicity. In addition, the redox-responsive chemical linkage can be triggered by redox substances in the tumor-specific microenvironment, enabling selective drug release. ,, Recently, RHPNs have caught significant attention for their great potential to enhance the effectiveness and safety of chemotherapeutic agents. , Despite these advantages, RHPNs are currently only in the preclinical research stage, with their antitumor efficacy limited by the challenges of simultaneously enhancing assembly ability and drug release rate. , Therefore, constructing RHPNs with a suitable chemical linkage to simultaneously enhance the assembly ability and drug release rate is critical for ensuring stability in systemic circulation and antitumor response in tumors.…”
Section: Introductionmentioning
confidence: 99%